Xtandi 80 MG tab 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FBUBM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,042
Award facts
- Contract value 100% obligated
- $10,042.17 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $10,042.17 delivery order to DMS Pharmaceutical Group Inc. on April 21, 2026, for XTANDI 80 MG tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).
DMS Pharmaceutical is a woman-owned small business serving as the sole regional prime vendor under PPV-G GEN V, a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036. Place of performance is Park Ridge, Illinois. The order is priced on a firm fixed-price basis with an ultimate completion date of April 21, 2026.
Quick answers
Who was awarded contract SPE2DR26FBUBM?
SPE2DR26FBUBM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 21, 2026.
How much is contract SPE2DR26FBUBM worth?
The government has obligated $10,042 on SPE2DR26FBUBM.
Is contract SPE2DR26FBUBM an order under another contract?
Yes. SPE2DR26FBUBM is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBUBM competed?
The extent of competition for SPE2DR26FBUBM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award